Dietary supplement health claims being reconsidered
The Food and Drug Administration, in accordance with an appeals court ruling, has revoked its regulations in which the agency stated its decision not to authorize health claims for four substance-disease relationships: dietary fiber and cancer, antioxidant vitamins and cancer, omega-3 fatty acids and coronary heart disease, and the claim that 0.8 mg of folate in dietary supplement form is more effective in reducing the risk of neural tube defect…

Premium Content
You've reached your monthly limit of free articles.
Access Food Technology
Log in Subscribe